Free Trial

National Vision (EYE) Competitors

National Vision logo
$23.01 -0.16 (-0.69%)
As of 06/30/2025 04:00 PM Eastern

EYE vs. STVN, GKOS, NARI, IRTC, TMDX, BLCO, SLNO, INSP, PRCT, and NVST

Should you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.

National Vision vs. Its Competitors

National Vision (NASDAQ:EYE) and Stevanato Group (NYSE:STVN) are both medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment.

National Vision currently has a consensus target price of $18.67, suggesting a potential downside of 18.88%. Given National Vision's higher possible upside, equities research analysts clearly believe National Vision is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.44
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86

Stevanato Group has a net margin of 11.14% compared to National Vision's net margin of -1.40%. Stevanato Group's return on equity of 10.00% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision-1.40% 3.44% 1.40%
Stevanato Group 11.14%10.00%6.03%

National Vision has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500.

In the previous week, Stevanato Group had 3 more articles in the media than National Vision. MarketBeat recorded 8 mentions for Stevanato Group and 5 mentions for National Vision. National Vision's average media sentiment score of 1.08 beat Stevanato Group's score of 0.64 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stevanato Group
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stevanato Group has lower revenue, but higher earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.82B1.00-$28.50M-$0.33-69.73
Stevanato Group€1.19B6.21€127.45M€0.5148.06

Summary

Stevanato Group beats National Vision on 10 of the 14 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EYE vs. The Competition

MetricNational VisionCONS PD IndustryStaples SectorNASDAQ Exchange
Market Cap$1.83B$33.10B$16.04B$8.90B
Dividend YieldN/A2.83%3.18%4.13%
P/E Ratio-69.7331.9219.4819.67
Price / Sales1.001.8167.15110.29
Price / Cash14.1615.9514.5827.49
Price / Book2.228.686.145.42
Net Income-$28.50M$1.19B$680.27M$248.34M
7 Day Performance-0.35%0.45%0.02%0.81%
1 Month Performance16.15%-0.16%-0.78%5.01%
1 Year Performance81.61%32.45%5.58%18.10%

National Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
2.5701 of 5 stars
$23.01
-0.7%
$18.67
-18.9%
+75.8%$1.83B$1.82B-69.7313,411Positive News
STVN
Stevanato Group
N/A€23.62
+1.4%
N/A+33.6%€7.15B€1.19B46.315,521News Coverage
Positive News
Analyst Forecast
Gap Down
GKOS
Glaukos
4.4001 of 5 stars
$96.80
-3.3%
$134.67
+39.1%
-12.6%$5.72B$383.48M-40.84780News Coverage
NARI
Inari Medical
0.4834 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
IRTC
iRhythm Technologies
1.0358 of 5 stars
$150.95
+3.6%
$138.60
-8.2%
+43.0%$4.65B$591.84M-48.072,000
TMDX
TransMedics Group
1.5402 of 5 stars
$127.53
+3.2%
$127.33
-0.2%
-11.0%$4.18B$441.54M93.77210Positive News
BLCO
Bausch + Lomb
3.3262 of 5 stars
$12.01
+2.3%
$15.54
+29.5%
-10.3%$4.15B$4.79B24.4413,500
SLNO
Soleno Therapeutics
4.6665 of 5 stars
$81.42
+1.8%
$107.10
+31.5%
+105.3%$4.03BN/A-17.6230
INSP
Inspire Medical Systems
4.807 of 5 stars
$129.88
-0.8%
$211.91
+63.2%
-3.4%$3.86B$802.80M59.851,246Positive News
PRCT
PROCEPT BioRobotics
2.5162 of 5 stars
$58.74
-2.5%
$90.00
+53.2%
-5.7%$3.33B$224.50M-34.55430
NVST
Envista
3.4268 of 5 stars
$18.90
+0.1%
$20.23
+7.0%
+17.7%$3.20B$2.51B-2.8912,300

Related Companies and Tools


This page (NASDAQ:EYE) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners